The company develops these treatments using Artificial Intelligence (AI). The AI program analyzes scientific papers. The results help the developers select natural ingredients that produce the desired effect. In some cases, the AI program analyzed more than 50,000 scientific papers during the development of a single treatment.
After completing the development, the company patents the new treatment and invites scientists to conduct clinical trials to test the safety and efficacy of the treatment. The trails follow FDA guidelines. The results of the clinical trials are reviewd by scientists and published in peer-reviewed medical journals.
Currently, Lilac Corp is offering four products: 1. Gene-Eden-VIR (against viruses), 2. Novirin (against viruses), 3. Nolopecia (for stimulating hair growth), and 4. Noacnin (for stimulating skin renewal).
Gene-Eden-VIR and Novirin are broad antiviral treatments. †
Nolopecia was designed to stimulate hair growth.†
Noacnin was designed to help the skin rejuvenate.†
Many doctors prescribe the Lilac Corp products to their patients. See, for instance, the following four prescriptions for Gene-Eden-VIR (some information was blacked out to protect the privacy of the people involved).